logo-loader

Arecor's Sarah Howell discusses results from successful phase I insulin trial

Published: 07:19 17 Dec 2019 EST

Arecor Ltd's CEO Sarah Howell caught up with Proactive London's Andrew Scott following the successful completion of the phase I trial for its ultra-rapid acting insulin for diabetics.

She says the product was shown to have a favourable profile when compared with standard treatments and the complete results have been submitted for publication at a big diabetes conference next year.

FTSE 100 awaits Rishi Sunak’s Budget today while oil majors rise with higher...

FTSE 100 opened higher helped by a strong start from the oil majors BP and Shell as more brokers predicted crude prices are going to rise higher. Attention will focus on Rishi Sunak’s Budget later today but for now the index is up 38 at 7,515.   Sunak’s announcement comes just after UK...

on 03/23/2022